Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology
City AM
—
Reply [EXM, STAR: REY] and the European Institute of Oncology (IEO) have launched a collaboration focused on the co-development and training of domain-specific Large Language Models for oncology.
The initiative brings together Reply’s expertise in building frontier generative models grounded in enterprise knowledge with the IEO’s clinical expertise and data assets to develop models tailored https://www.cityam.com/reply-and-ieo-launch-collaboration-to-co-develop-and-train-domain-specific-large-language-models-for-oncology/">[...]
Ovarian Cancer Drug Approved by NHS
- NHS approves first new ovarian cancer treatment for 20 years Sky News —
- Breakthrough ovarian cancer drug offers patients more time and better quality of life BBC News —
- Hope for thousands of ovarian cancer patients as new drug which slashes risk of death by a third is made available on the NHS Daily Mail —
- Life-prolonging drug for advanced ovarian cancer gets go-ahead in England The Guardian —
- 'Significant breakthrough' as new ovarian cancer treatment approved for NHS use The Standard —